Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/155843
Autor(es): Barreira-Silva, P
Melo-Miranda, R
Nobrega, C
Roque, S
Serre-Miranda, C
Borges, M
Armada, G
Calçada, DS
Behar, SM
Appelberg, R
Correia-Neves, M
Título: IFNγ and iNOS-Mediated Alterations in the Bone Marrow and Thymus and Its Impact on Mycobacterium avium-Induced Thymic Atrophy
Editor: Frontiers Media
Data de publicação: 2021
Resumo: Disseminated infection with the high virulence strain of Mycobacterium avium 25291 leads to progressive thymic atrophy. We previously showed that M. avium-induced thymic atrophy results from increased glucocorticoid levels that synergize with nitric oxide (NO) produced by interferon gamma (IFNg) activated macrophages. Where and how these mediators act is not understood.We hypothesized that IFNg and NO promote thymic atrophy through their effects on bone marrow (BM) T cell precursors and T cell differentiation in the thymus. We show that M. avium infection cause a reduction in the percentage and number of common lymphoid progenitors (CLP). Additionally, BM precursors from infected mice show an overall impaired ability to reconstitute thymi of RAGKO mice, in part due to IFNg. Thymi from infected mice present an IFNg and NO-driven inflammation.When transplanted under the kidney capsule of uninfectedmice, thymi from infectedmice are unable to sustain T cell differentiation. Finally, we observed increased thymocyte death via apoptosis after infection, independent of both IFNg and iNOS; and a decrease on active caspase-3 positive thymocytes, which is not observed in the absence of iNOS expression. Together our data suggests that M. avium-induced thymic atrophy results from a combination of defects mediated by IFNg and NO, including alterations in the BM T cell precursors, the thymic structure and the thymocyte differentiation.
Assunto: BM T cell precursors
IFN gamma
Mycobacterium avium infection
nitric oxide
thymocyte differentiation
thymus premature atrophy
DOI: 10.3389/fimmu.2021.696415
URI: https://hdl.handle.net/10216/155843
Fonte: Frontiers in Immunology, vol.12:696415
Informação Relacionada: info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50026%2F2020/PT
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50026%2F2020/PT
info:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBD%2F73544%2F2010/PT
Tipo de Documento: Artigo em Revista Científica Internacional
Condições de Acesso: openAccess
Licença: https://creativecommons.org/licenses/by/4.0/
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.3389-fimmu.2021.696415.pdf7.74 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons